(Approval lapsed) KamRAB 150 IU/ml Solution for Injection (Human Rabies immunoglobulin)
Section 19A approved medicine
(Approval lapsed) KamRAB 150 IU/ml Solution for Injection (Human Rabies immunoglobulin)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 517
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
IMOGAM RABIES PASTEURIZED human rabies immunoglobulin 150 IU/mL injection vial - ARTG 72931
Indication(s)
KamRAB 150 IU/mL Solution for injection - 2mL vial (Human Rabies immunoglobulin) in conjunction with the standard series of Rabies Vaccine vaccinations, is indicated for individuals suspected of exposure to rabies, particularly severe exposure, with one exception: persons who have been previously immunized with Rabies Vaccine.
Previously immunized persons are those who have had a documented rabies virus neutralizing antibody titer and who have completed one of the recommended regimens (pre-exposure or post-exposure) with a cell culture vaccine or another vaccine. Administer only vaccine to these persons (i.e., post-exposure for a person previously vaccinated).